CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a threatening hematological malignant disease in which new successful approaches in therapy are needed. Cyclin-dependent kinase 6 (CDK6), a regulatory enzyme of the cell cycle that plays an important role in leukemogenesis and the maintenance of leukemia stem cells (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Yi, Jin-Mou, Liu, Yi, Chen, Cong, Zhang, Kai-Xuan, Zhou, Cheng, Zhan, Hui-En, Zhao, Liang, Morales, Stephanie, Zhao, Xie-Lan, Zeng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882723/
https://www.ncbi.nlm.nih.gov/pubmed/33597968
http://dx.doi.org/10.3389/fgene.2020.600227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882723/
https://www.ncbi.nlm.nih.gov/pubmed/33597968
http://dx.doi.org/10.3389/fgene.2020.600227

Ejemplares similares